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A remarkably wide variety of chemical
structures, produced both by nature and by
man, have estrogenic activity. While the
molecular details of this structural perva-
siveness of estrogenic activity are not
known, it is less surprising ifone considers
that assays for estrogenic activity are
extremely sensitive and can operate over a
potency range of 10 million, that most
estrogens share the common structural
motifofa phenol or the functional equiva-
lent of a phenol, and that most estrogens
are lipophilic and thus can be resistant to
metabolism and undergo bioconcentration.
Evaluating the effect and potential risk of
this structurally pervasive estrogenic activ-
ity is a complex issue, and a number offac-
tors should be considered: a) while
excessive and aberrant exposure ofhumans
and animals to estrogens may be detrimen-
tal, a certain degree ofexposure to natural
estrogens from both endogenous and
exogenous natural sources is unavoidable;
b) estrogens from various sources may have
beneficial as well as undesirable effects;
c) their action may be selective on certain
target sites; and d) they may have other
nonestrogenic toxic or beneficial effects.
Thus, one must be aware ofthe widespread
potential for compounds to have estrogenic
activity, and one must evaluate individually
whether the activity ofeach ofthese estro-
genic substances and our exposure to
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them is a benefit or a detriment to animal
and human health.
Compounds with a remarkable array of
chemical structures-of natural origin or
produced by humans-have estrogenic
activity. Estrogens of natural origins
include not only the ovarian estrogenic
steroids, but many natural products pro-
duced by plants and microbes. Some of
these latter compounds are derived from
components of normal dietary foodstuffs
(legumes and grains) and have their activity
enhanced by the activity of gut microflora
of animals and humans; others enter the
diet ofhumans or livestock only via conta-
mination. Synthetic estrogens include not
only nonsteroidal hormone mimics but
phenolic impurities found in pH indicator
dyes and phenolic components used in the
fabrication ofpolycarbonate plastics and as
the core components of nonionic deter-
gents. A number of industrial chemicals
and agricultural pesticides and their
metabolites, some of which are multiply
chlorinated, also have estrogenic activity.
Representative structures ofestrogens from
these diverse sources are shown in Figure 1.
How can it be that compounds from so
many different sources have estrogenic
activity? In fact, the variety of chemical
structures that elicit an estrogenic response
in sensitive test systems is enormous; in
this regard the estrogen receptor system
may well be unique in terms of the struc-
tural diversity of its effective stimulants.
Without a greater knowledge of the
molecular details of the structure of the
estrogen receptor and its interaction with
ligands, it is difficult to speculate as to the
reason for this tolerance ofstructural diver-
sity. Nevertheless, some points of interest
should be made.
Potent estrogens show cell growth stim-
ulatory activity at exceedingly low con-
centrations. When using the growth
rate of estrogen-sensitive cells to assay
for estrogenic activity, growth stimula-
tion by estradiol can be observed at a
concentration of 10-12M, and half-
maximal stimulation is usually observed
at 3 x 10-11 M. (In fact, the potency of
estrogens in this assay appears to exceed
their affinity for the estrogen receptor
by a factor of about 10.) Since other
compounds can be assayed at concen-
trations of up to 10-5 to 10-4 M in
these cell systems, it is not surprising
that even those with very weak activity
can give a detectable response. It is rare
to have a functional assay system that
can operate over a concentration range
of10 millionfold.
There are some common structural
motifs among compounds with estro-
genic activity. Most compounds that
have estrogenic activity are phenols.
Others, however, are nonphenolic aro-
matic compounds, which in some cases
may undergo bioactivation by metabo-
lism to phenols (e.g., methoxychlor).
Some of these may act even without
this bioactivation, but these com-
pounds are generally of relatively low
potency (e.g., o,p'-DDT). Some com-
pounds with estrogenic activity are not
even aromatic, but this is unusual, and
these compounds are often ofquite low
potency (e.g., endosulfan, kepone,
toxaphene). One should also note that
even some of these compounds may
bear the functional equivalent ofa phe-
nol; for instance, the cyclic sulfite
group in endosulfan is a polar function
that can act as a hydrogen bond accep-
tor, and the ketone group in kepone,
because of ring strain, is likely to be
partially hydrated, affording a gem diol
function that can participate in hydro-
gen bonding. Thus, the most rudimen-
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Figure 1. The variety of structures of compounds that have estrogenic activity is displayed according to various
designations and sources.
estrogenic activity is a phenol that is
relatively unhindered at the ortho posi-
tions, but then contains a rather bulky,
hydrophobic structure attached to the
meta or para positions. The further
details of the structure have a major
effect on the potency ofthe compound,
but this basic motif will generally
ensure some estrogenic activity (at least
enough to be detected by an assay that
has a potency range of 10 million).
Estrogens tend to be rather hydropho-
bic. As the structural mimicry of an
estrogen deviates more and more from
that ofestradiol, some estrogenic activ-
ity is generally ensured by having the
compound be hydrophobic. This is
perhaps why estrogenic activity is found
with a number ofthe chlorinated pesti-
cides and biphenyls such as o,p'-DDT,
DDE, PCBs, methoxychlor, kepone,
and toxaphene. The last ofthese is per-
haps the most unusual structure (or
mixture of structures) to display estro-
genic activity and is probably the most
hydrophobic. Each chlorine substituent
is predicted to elevate the lipophilicity
by a factor of2- to 9-fold (as estimated
by the octanol-water partition coeffi-
cient). It is perhaps a conspiracy of
nature that hydrophobic compounds,
particularly those resistant to metabolic
degradation such as polychlorinated
materials or those with highly branched
alkyl substituents, persist in the environ-
ment and may undergo bioconcentra-
tion, thereby amplifying the potential
exposure ofthese agents to those at the
end offood chains. In addition, because
of their lipophilicity, these compounds
can accumulate to high levels in lipids
and membranes from which they can
slowly be released to provide a low, per-
sistent level of compound in blood;
such continuous dosage may be most
effective in stimulating certain estro-
genic responses.
These three factors-an extremely sen-
sitive assay system with a very wide
(107-fold) response range, a general respon-
siveness to phenols, and the added enhance-
ment of activity and environmental
persistence due to hydrophobicity-con-
spire to endow a large variety of chemical
structures with some estrogenic activity.
Regardless of the molecular details of
ligand receptor interaction or the transduc-
tion ofthe signal ofreceptor activation into
response that are responsible for this fact,
the consequences ofthe structural diversity
ofestrogens in terms ofhuman and animal
health need to be soberly evaluated. Some
effects of estrogens in unwanted places,
such as impurities in pH indicator dyes
used in cell culture media or components
that leach out ofpolycarbonate media bot-
tles, are simply nuisances that confound the
results of cell culture experiments. Other
exposures such as those ofpesticide residues
from application and production, in some
cases amplified by bioconcentration, may
have profoundly detrimental effects on the
health and reproductive capacity ofwildlife
(and possiblyofhumans).
While estrogenic materials in food-
stuffs, either as normal endogenous sec-
ondary metabolites of plants or the
products of microbial infestation (such as
moldy corn), can be destructive to the fer-
tility oflivestock, related estrogens (or their
precursors from which weak estrogens are
produced by the reductive metabolism of
gut microflora) may, in fact, be beneficial
to humans. These compounds, to which
humans are exposed in large doses through
the normal intake ofhealthy foodstuffs, are
generally compounds of low potency, and
their net effect on the endogenous human
endocrine system may actually be that of
estrogen antagonism. Weak, short-acting
estrogens such as estriol are known to
reduce the effect of potent estrogens such
as estradiol and thereby have a net protec-
tive effect. Furthermore, some ofthe weak
estrogens or their precursors in foodstuffs
may have other biological activities that are
beneficial to human health, such as the
inhibition of angiogenesis. On the other
hand, some compounds with estrogenic
activity may have a spectrum of toxicities
that is fully independent of the estrogen
response system. Another facet to consider
is the selectivity of estrogen action.
Estrogens cause many responses and have
myriad effects on health and reproductive
function; it is now becoming apparent
that alterations in their structure can have
variable effects on these activities. Thus,
the potency and agonist/antagonist bal-
ance ofdifferent estrogens can depend on
the particular species, tissue, or response
being investigated.
These numerous considerations not-
withstanding, one should not lose sight ofa
number ofsimple facts about human expo-
sure to estrogens-the estrogens may be as
good as they are bad, but exposure to estro-
genic substances (at least those from natural
sources) is, by almost any reasonable stan-
dard, inescapable. Most human diets con-
tain large quantities of weak estrogenic
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substances (or their precursors) as natural
components of our food. Estrogens are
produced endogenously by humans (by
males as well as females) and, aside from
unusual cases, the major exposure that
humans have to potent estrogens is to
those oftheir own production.
The bottom line is simply this: one
must be aware of the widespread potential
for compounds with varying structures, but
sharing the general structural motifs
outlined above, to have estrogenic activity.
On the other hand, one must try-on a
case by case basis-to come to a better
understanding of whether the activity of
these compounds and our exposure to
them is a detriment or a benefit to animal
and human health.
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